Biomind Labs Inc.
BMND
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 370.20K | 384.00K | 379.40K | 359.20K | 347.50K |
| Depreciation & Amortization | 6.60K | 8.80K | 8.80K | 6.60K | 6.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 393.00K | 409.00K | 404.50K | 402.50K | 440.20K |
| Operating Income | -393.00K | -409.00K | -404.50K | -402.50K | -440.20K |
| Income Before Tax | -45.50K | -141.10K | -260.50K | -704.90K | -796.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.05 | -0.14 | -0.26 | -0.70 | -0.80 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.50K | -141.10K | -260.50K | -704.90K | -796.00K |
| EBIT | -393.00K | -409.00K | -404.50K | -402.50K | -440.20K |
| EBITDA | -386.30K | -400.10K | -395.50K | -394.00K | -423.30K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 310.19M | 307.38M | 304.57M | 301.76M | 299.05M |
| Average Diluted Shares Outstanding | 310.19M | 307.38M | 304.57M | 301.76M | 299.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |